It is intriguing that the expression of two ABC transporters with different substrate specificity was increased simultaneously by long-term exposure to eribulin in seven breast cancer cell lines, regardless of the receptor status of the cell lines. The gene discussed is ABCG2; the disease is breast carcinoma.